Sivia Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History

Sivia Capital Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.73M	Sell	47,373 -41,210	-47%	-$2.37M	0.33%	47
2026 Q1	$5.37M	Buy	88,583 +41,261	+87%	+$2.41M	1.04%	13
2025 Q4	$2.55M	Buy	47,322 +38,941	+465%	+$1.87M	0.52%	23
2025 Q3	$378K	Buy	8,381 +904	+12%	+$42.2K	0.11%	248
2025 Q2	$346K	Buy	7,477 +2,786	+59%	+$137K	0.12%	229
2025 Q1	$286K	Buy	4,691 +399	+9%	+$23.3K	0.13%	169
2024 Q4	$243K	Buy	4,292 +410	+11%	+$22.9K	0.12%	148
2024 Q3	$201K	Buy	+3,882	New	+$182K	0.12%	196

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sivia Capital Partners's BMY Position: Q2 2026 in Review

Sivia Capital Partners reduced its Bristol-Myers Squibb (BMY) stake by 47% in Q2 2026, selling an estimated $2.37M and leaving 47,373 shares worth $2.73M. The position accounts for 0.33% of the portfolio, ranked #47.

Sivia Capital Partners first reported a position in BMY in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.37M in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Sivia Capital Partners held 47,373 shares of Bristol-Myers Squibb worth $2.73M as of Q2 2026.
Sivia Capital Partners sold 41,210 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.37M.
Bristol-Myers Squibb made up 0.33% of Sivia Capital Partners's portfolio in Q2 2026, its #47 holding.
Sivia Capital Partners first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 8 quarters since.
Sivia Capital Partners's Bristol-Myers Squibb position peaked at $5.37M in Q1 2026.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.